Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2004; 25(01): 39-42
DOI: 10.1055/s-0041-1733064
Original Article

Malignant Germ Cell Tumours of Ovary

SUNESH KUMAR
Department of Medical Oncology & Gynaecology, AIIMS, New Delhi-29, India
,
L KUMAR
Department of Medical Oncology & Gynaecology, AIIMS, New Delhi-29, India
,
S BARGE
Department of Medical Oncology & Gynaecology, AIIMS, New Delhi-29, India
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
28 March 2022

© 2004. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Williams SD. Current management of ovarian germ cell tumors. Oncology 1994; 8:53-60.
  • 2 Smales E and Pecham MJ. Chemotherapy of germ cell ovarian tumors : First line treatment with etoposide, bleomycin and cisplatin or carboplatin. Eur J Cancer Clin Oncol 1987; 23:469-72.
  • 3 Gershenson DM , Morris M , Cangir A, Kavanagh JJ, Stringer CA, Edwards CL, Silva EG and Wharton JT. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide and cisplatin. J Clin Oncology1990;8:715- 720
  • 4 Williams SD, Blessing JA, Liao Shu-Yuan, Ball H, and Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide and bleomycin: A trial of the Gynecologic Oncology Group. J Clin. Oncol 1994;12:701-706.
  • 5 Hitchins RN, Newlands ES , Smith DB, Begent RHJ, Rustin GJS and Bagshawe KD. Long term outcome in patients with germ cell tumours treated with POMB-ACE chemotherapy. Comparision of commonly used classification systems of good and poor prog¬nosis. Brit J Cancer 1989;59:236-242.
  • 6 Dark GG, Bower M, Newlands ES, Paradinas F, and Rustin GJS. Surveillance Policy for stage 1 ovarian germ cell tumors. J Clin Oncol 1997;15:620-624.
  • 7 Loehrer PJ, Einhorn LH and Williams SD. VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer. J Clin Oncology 1986;4:528-36.
  • 8 Brewer M, Gershenson DM, Herzog CE, el al. Outcome and reproductive function after chemotherapy for ova¬rian dysgerminoma. J Clin Oncol 1999;17:2670-2675.
  • 9 Laufer MR. Reproductive issues for cancer patients/sur¬vivors. J Clin Oncol 1999:17:2631-32.
  • 10 Low JH, Perrin LC, Crandon AJ and Hacker NF. Con¬servative surgery to preserve ovarian function in pa¬tients with malignant ovarian germ cell tumors.: A re¬view of 74 cases. Cancer 2000:89:391-8.